Stock PIRS PIERIS PHARMACEUTICALS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Press Releases Pieris Pharmaceuticals Inc OTC Bulletin Board

Equities

PIRS

US7207951036

End-of-day quote OTC Bulletin Board
Other stock markets
- - Intraday chart for Pieris Pharmaceuticals Inc
Apr. 19 Pieris Pharmaceuticals Shares Fall After 1-for-80 Reverse Stock Split Announcement MT
Apr. 03 North American Morning Briefing : Powell Awaited -2- DJ

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Pieris Pharmaceuticals Announces 1-for-80 Reverse Stock Split
AQ
Pieris Pharmaceuticals : Announces 1-for-80 Reverse Stock Split - Form 8-K
PU
Pieris Pharmaceuticals Announces Strategy to Maximize Partnered Milestone and Royalty Potential
AQ
Pieris Pharmaceuticals : Announces Strategy to Maximize Partnered Milestone and Royalty Potential - Form 8-K
PU
Pieris Pharmaceuticals: Q3 Earnings Snapshot
AQ
Dr. Hitto Kaufmann appointed Chief Scientific Officer of Hansa Biopharma
AQ
Dr. Hitto Kaufmann appointed Chief Scientific Officer of Hansa Biopharma
AQ
Pieris Pharmaceuticals Announces Milestone Achievement for Boston Pharmaceuticals Initiation of Phase 1/2 Study of BOS-342, a 4-1BB/GPC3 Immuno-Oncology Bispecific
AQ
Pieris Pharmaceuticals : Provides Strategic Update and Announces Restructuring - Form 8-K
PU
Pieris Pharmaceuticals : Announces AstraZeneca Discontinuation of Phase 2a Trial of Elarekibep (PRS-060/AZD1402) Due to New Non-Clinical Safety Findings From 13-week Toxicology Study - Form 8-K
PU
PIERIS PHARMACEUTICALS, INC. : Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
PIERIS PHARMACEUTICALS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
PIERIS PHARMACEUTICALS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)
AQ
PIERIS PHARMACEUTICALS, INC. : Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
Pieris Pharmaceuticals: Q1 Earnings Snapshot
AQ
PIERIS PHARMACEUTICALS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
AQ
PIERIS PHARMACEUTICALS, INC. : Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
PIERIS PHARMACEUTICALS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
PIERIS PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
AQ
PIERIS PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PIRS Stock
  4. PIRS Stock
  5. News Pieris Pharmaceuticals Inc
  6. Press Releases